Superior outcomes of nodal metastases compared to visceral sites in oligometastatic colorectal cancer treated with stereotactic ablative radiotherapy
Open Access
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 151, 280-286
Abstract
No abstract availableKeywords
Funding Information
- Cancer Research UK
This publication has 35 references indexed in Scilit:
- Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastasesBMC Cancer, 2020
- Stereotactic radiation therapy in oligometastatic colorectal cancer: outcome of 102 patients and 150 lesionsClinical & Experimental Metastasis, 2019
- Predictive factors for survival of oligometastatic colorectal cancer treated with Stereotactic body radiation therapyRadiotherapy and Oncology, 2019
- Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-upRadiation Oncology, 2018
- Stereotactic body radiotherapy for oligo-metastatic liver disease – Influence of pre-treatment chemotherapy and histology on local tumor controlRadiotherapy and Oncology, 2017
- Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trialThe Lancet Oncology, 2015
- Combining Radiotherapy and Cancer Immunotherapy: A Paradigm ShiftJNCI: Journal of the National Cancer Institute, 2013
- Oligometastases revisitedNature Reviews Clinical Oncology, 2011
- Treatment recommendations for metastatic colorectal cancerClinical and Translational Oncology, 2011
- Liver metastases from colorectal cancer: Lessons from past and present clinical studiesBritish Journal of Surgery, 1996